(ITE) SPDR Bloomberg Barclays - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A6727

US Treasury Bonds, Government Securities, Intermediate Term Bonds

Description: ITE SPDR Bloomberg Barclays

The SPDR Bloomberg Barclays Intermediate Term Treasury ETF (NYSE ARCA:ITE) is designed to track the performance of the Bloomberg Barclays 3-10 Year U.S. Treasury Index, providing investors with exposure to intermediate-term U.S. Treasury securities. The fund invests at least 80% of its assets in securities that comprise the index or those with similar economic characteristics.

As an ETF in the Intermediate Government category, ITE offers a relatively low-risk investment option with a focus on income generation through interest payments. The funds underlying index is composed of U.S. Treasury securities with maturities between 3 and 10 years, which are generally considered to be of high credit quality. With an AUM of $8.7 billion, ITE is a sizable and liquid ETF, making it a viable option for investors seeking to manage their fixed income exposure.

From a performance perspective, key metrics to consider include the funds yield, duration, and credit quality. The yield on ITE is likely to be influenced by changes in interest rates, with longer-duration securities being more sensitive to rate movements. As a Treasury ETF, credit risk is minimal, but interest rate risk is a key consideration. Investors should also be aware of the funds expense ratio, which can impact net returns over time. With a tight tracking error, ITE is likely to closely follow the performance of its underlying index, making it a reliable choice for investors seeking intermediate-term Treasury exposure.

In terms of key performance indicators (KPIs), investors may want to monitor the funds tracking error, yield to maturity, and duration to assess its performance and risk profile. Additionally, changes in interest rates, inflation expectations, and economic growth may impact the funds performance, making it essential to stay informed about macroeconomic trends and their potential impact on the Treasury market.

Additional Sources for ITE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ITE ETF Overview

Market Cap in USD 8,713m
Category Intermediate Government
TER 0.06%
IPO / Inception 2007-05-23

ITE ETF Ratings

Growth Rating -7.97
Fundamental -
Dividend Rating 71.1
Rel. Strength 9.15
Analysts -
Fair Price Momentum 27.68 USD
Fair Price DCF -

ITE Dividends

Dividend Yield 12m 3.49%
Yield on Cost 5y 3.30%
Annual Growth 5y 33.24%
Payout Consistency 89.2%
Payout Ratio %

ITE Growth Ratios

Growth Correlation 3m 75.5%
Growth Correlation 12m 57.6%
Growth Correlation 5y -48%
CAGR 5y -0.93%
CAGR/Max DD 5y -0.06
Sharpe Ratio 12m -0.93
Alpha 0.42
Beta -0.068
Volatility 4.35%
Current Volume 2060.4k
Average Volume 20d 1495.1k
Stop Loss 27.7 (-3%)
What is the price of ITE shares?
As of August 03, 2025, the stock is trading at USD 28.57 with a total of 2,060,400 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -0.17%, over three months by +0.35% and over the past year by +3.46%.
Is SPDR Bloomberg Barclays a good stock to buy?
Neither. Based on ValueRay´s Analyses, SPDR Bloomberg Barclays is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -7.97 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ITE is around 27.68 USD . This means that ITE is currently overvalued and has a potential downside of -3.12%.
Is ITE a buy, sell or hold?
SPDR Bloomberg Barclays has no consensus analysts rating.
What are the forecasts for ITE share price target?
According to our own proprietary Forecast Model, ITE SPDR Bloomberg Barclays will be worth about 29.9 in August 2026. The stock is currently trading at 28.57. This means that the stock has a potential upside of +4.66%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.9 4.7%